General MedicationsORALGeneric
CITALOPRAM HYDROBROMIDE
CITALOPRAM HYDROBROMIDE
Standard Dose
EQ 40MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 077668 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CITALOPRAM HYDROBROMIDE Form and strength CAPSULE;ORAL - EQ 40MG BASE Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2024-11-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 077668 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CITALOPRAM HYDROBROMIDE Form and strength CAPSULE;ORAL - EQ 40MG BASE Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2024-11-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.